Joel-Cohen incision
Joel-Cohen incision is a type of surgical incision used primarily in gynecology and obstetrics. It was first described by Joel Cohen, a South African gynecologist, in 1973. The incision is a type of transverse incision made in the lower abdomen, specifically in the suprapubic region. It is often used in cesarean section procedures and is known for its benefits in terms of reduced blood loss, less post-operative pain, and quicker recovery times.
History[edit | edit source]
The Joel-Cohen incision was first described in 1973 by Joel Cohen, a South African gynecologist. It was initially used in gynecological surgeries, but its benefits soon led to its adoption in obstetric procedures, particularly cesarean sections.
Procedure[edit | edit source]
The Joel-Cohen incision is a type of transverse incision made in the lower abdomen. The incision is made approximately 3 cm above the pubic symphysis, in the suprapubic region. The incision is then extended laterally to the right and left, creating a 'smile' shape. The underlying muscles are not cut, but are instead separated along their natural fibers, reducing the risk of muscle damage and subsequent complications.
Benefits[edit | edit source]
The Joel-Cohen incision is associated with several benefits compared to other types of surgical incisions. These include reduced blood loss during surgery, less post-operative pain, and quicker recovery times. The incision also allows for better visibility of the surgical field, which can improve surgical outcomes.
Risks and Complications[edit | edit source]
As with any surgical procedure, the Joel-Cohen incision carries some risks. These include the risk of infection, the risk of wound dehiscence (separation of the wound edges), and the risk of incisional hernia. However, these risks are generally lower with the Joel-Cohen incision compared to other types of surgical incisions.
See Also[edit | edit source]
Joel-Cohen incision Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD